Rockbridge Investment Management, LCC - FIVE PRIME THERAPEUTICS INC ownership

FIVE PRIME THERAPEUTICS INC's ticker is FPRX and the CUSIP is 33830X104. A total of 96 filers reported holding FIVE PRIME THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.69 and the average weighting 0.0%.

Quarter-by-quarter ownership
Rockbridge Investment Management, LCC ownership history of FIVE PRIME THERAPEUTICS INC
ValueSharesWeighting
Q4 2020$8,000
+300.0%
457
+30.6%
0.00%
Q3 2020$2,0000.0%3500.0%0.00%
-100.0%
Q2 2020$2,0003500.00%
Other shareholders
FIVE PRIME THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 115,500$2,531,0000.89%
AWM Investment Company, Inc. 150,000$3,288,0000.64%
BB BIOTECH AG 827,500$18,139,0000.51%
Virtus ETF Advisers LLC 17,371$381,0000.48%
Rock Springs Capital Management LP 425,000$9,316,0000.42%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 450,728$9,880,0000.39%
Telemetry Investments, L.L.C. 44,176$968,0000.37%
RTW INVESTMENTS, LP 100,377$2,200,0000.37%
Eventide Asset Management 315,000$6,905,0000.36%
ACUTA CAPITAL PARTNERS, LLC 52,500$1,151,0000.22%
View complete list of FIVE PRIME THERAPEUTICS INC shareholders